Portfolia

What Portfolia does

Portfolia is a privately held venture capital fund manager founded in 2014 by Trish Costello and headquartered in San Mateo, California. The firm operates a thematic, community-driven fund platform designed to provide individual accredited investors—predominantly women—with institutional-quality venture capital exposure across 15+ thematic funds spanning women's health, femtech, active aging and longevity, food and agtech, green and sustainability, and underrepresented founders (Rising America). Portfolia pioneered the first U.S. venture fund exclusively dedicated to women's health in 2018, a category that has since grown into the firm's flagship vertical with a portfolio of 46+ companies and 100+ investments.

The firm's core technology consists of an online member investment portal that enables 2,000+ accredited investors across 48 U.S. states and 20 countries to review fund details, complete subscription documents, and access portfolio updates. The platform supports virtual events, webinars, and educational content delivery, including the annual Investor Summit and the Summer of Women's Health Innovation series. Portfolia does not operate proprietary AI/ML systems; the platform's value derives from direct distribution, education infrastructure, and human-led deal diligence by a network of 15+ sector-specialist venture partners.

Portfolia's business model is the standard venture fund economics: it earns recurring management fees (typically ~2% annually) on assets under management across its 15+ thematic fund vehicles, plus carried interest on fund profits above negotiated hurdle rates earned by the GP upon successful portfolio exits. The firm employs 101-250 people and is led by Founder/CEO Trish Costello and CFO/COO Tammi Janzen. Since inception, Portfolia has made 165+ investments across 115+ portfolio companies, including three unicorns, and participates in rounds alongside institutional co-investors such as Insight Partners, RA Capital, Overwater Ventures, and strategic corporates including Hologic, Labcorp, and Bruker.

Name

Portfolia

Legal name

Portfolia, Inc.

Website

https://portfolia.co

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

101–250 employees

Short description

Portfolia is a privately held venture capital firm operating 15+ thematic funds designed for individual accredited investors, predominantly women, with a flagship focus on women's health and femtech. The firm manages 2,000+ LP members across 48 states and 20 countries and has backed 115+ portfolio companies including three unicorns.

Ownership category

akta.pro rank

Product category

Venture Capital Fund Management

NAICS

Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Endowment / OCIO-Style Multi-Manager Platforms (FSANAGAG)

akta.pro secondary industries

Emerging Manager / Seeding Platforms (Multi-Manager) (FSANAGAF), Managed Account / SMA Multi-Manager Platforms (FSANAGAL), Thematic / Sector-Focused Multi-Manager Platforms (FSANAGAH)

Keywords

• Thematic venture funds
• Women's health investing
• Femtech venture capital
• Accredited investor platform
• Venture fund management

Headquarters

HQ city

San Mateo

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Fund Management Fees: Recurring management fees charged on assets under management across Portfolia’s 15+ thematic venture funds, paid by limited partners over the life of each fund.
2. Carried Interest / Performance Fees: Performance-based carried interest on fund profits earned above negotiated hurdle rates, distributed to the GP (Portfolia) upon successful exits in portfolio companies.
3. Multi-Year LP Capital Commitments: Limited partners commit capital to each fund on a multi-year basis (typical venture fund lockup), with capital called over the investment period of each fund.

Pricing tiers

Go-to-market motion4 records

Distribution channels3 records

Marketing channels9 records

Core offering

Portfolia is a venture capital fund manager that creates and operates thematic VC funds (such as Women's Health, Femtech, Food & Agtech, Active Aging & Longevity, Rising America, Green & Sustainability, Rising Tide, Consumer I, and Enterprise I) and sells limited-partner interests in those funds to accredited individual investors, predominantly women. The firm pools LP capital commitments, sources and invests in early-stage companies aligned with each theme, and provides reporting and investor engagement through a member portal.

Product overview

No verifiable source passages with resolvable source IDs were provided in the input to extract a product/service overview.

Differentiator

Problem solved

Functional benefit

Brands

• Women's Health Fund (I, II, III, IV): Portfolia's flagship thematic venture fund vehicle focused exclusively on women's health; first launched in 2018 as the first U.S. VC fund dedicated to the sector.
• Rising America Fund (I, II, III)
• Femtech Fund (I, II, III)
• Active Aging & Longevity Fund (I, II)
• Food & Agtech Fund
• Green & Sustainability Fund

Products and services

• Women's Health Fund IV Thematic venture capital fund investing in early-stage companies focused on women's health; offered to accredited individual investors as a limited-partner interest.
• Femtech Funds (I, II, III) Thematic venture capital funds targeting femtech and women's-health technology companies; offered to accredited individual investors as LP interests.
• Active Aging & Longevity Funds (I, II) Thematic venture capital funds investing in companies addressing active aging, longevity, and aging-population health and consumer needs; offered to accredited individual investors as LP interests.
• Food & Agtech Fund Thematic venture capital fund investing in food and agricultural-technology companies; offered to accredited individual investors as LP interests.
• Green & Sustainability Fund Thematic venture capital fund investing in companies advancing environmental sustainability and green technologies; offered to accredited individual investors as LP interests.
• Rising America Fund III Thematic venture capital fund investing in companies aligned with Rising America themes; offered to accredited individual investors as LP interests.
• Rising Tide, Consumer I, and Enterprise I Funds Earlier-generation thematic venture capital funds (Rising Tide, Consumer I, Enterprise I) in Portfolia's fund family covering broader consumer, enterprise, and inclusive-economy themes; offered to accredited individual investors as LP interests.

Quantifiable outcome

• 2,000+ accredited investors in Portfolia’s community across 48 states and 20 countries
• +3 more outcomes

Segments4 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• HologiccoreStrategic or Co-development Partner · 1 January 2024Strategic corporate co-investor with Portfolia in Mercy BioAnalytics’ Series B, providing women’s-health commercial validation.
• Bruker ScientificminorStrategic or Co-development Partner · 1 January 2024Strategic corporate co-investor with Portfolia in Mercy BioAnalytics’ Series B, adding life-sciences instrumentation validation.
• LabcorpminorStrategic or Co-development Partner · 1 January 2024Strategic corporate co-investor with Portfolia in Mercy BioAnalytics’ Series B, anchoring diagnostics commercial partnerships.
• Columbia University (Gameto clinical trial site)coreStrategic or Co-development Partner · 1 January 2024Academic clinical-trial partner for Portfolia portfolio company Gameto, supporting preclinical and clinical research in women’s reproductive health.
• Prelude Fertility / Inception (Gameto clinical partner)coreStrategic or Co-development Partner · 1 January 2024Fertility-clinic clinical partner for Portfolia portfolio company Gameto, anchoring real-world deployment of women’s-health innovation.
• Shady Grove Fertility / US Fertility (Gameto clinical partner)coreStrategic or Co-development Partner · 1 January 2024Fertility-clinic clinical partner for Portfolia portfolio company Gameto, enabling clinical validation and commercial rollout.

Scale indicators13 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Female Founders Fund: Early-stage venture fund investing in women-led companies across consumer, health, and tech — a direct thematic peer to Portfolia with a similar mission of expanding venture access for women, though with a broader sector mandate than Portfolia's themed-vertical approach.
• Steel Sky Ventures: Venture capital fund focused exclusively on women's health startups — the closest direct competitor to Portfolia's Women's Health Funds, with overlapping LP base and competing for the same founder community in femtech and women's health.
• Coyote Ventures: Early-stage venture fund investing in women's health and wellness companies — operates in the same thematic niche as Portfolia's Women's Health Funds, backing femtech and consumer health startups with similar LP demographic.
• SoGal Ventures: Global venture fund backing diverse and female founders — a direct thematic peer to Portfolia's broader portfolio (Rising America, Femtech), with a similar mission of increasing venture access for women and an international footprint.
• Halogen Ventures: Early-stage venture fund investing in consumer tech companies led by women and people of color — overlaps with Portfolia's Rising America and consumer-oriented thematic funds in target founder demographic.
• Astia: Global venture firm and expert network investing in women-led companies across health, tech, and life sciences — comparable to Portfolia in mission and a similar curated community model for both founders and LPs.
• Rethink Impact: Impact-focused venture fund investing in women, people of color, and underserved communities — directly comparable to Portfolia's Rising America fund and broader impact-thesis mandate, with similar LP demographics.
• BBG Ventures: Early-stage venture fund backing female and diverse founders — directly comparable to Portfolia's Rising America fund, with similar seed-stage check size and founder-community model.

Emerging players

• Plum Alley Investments: Member-driven investment platform enabling women to invest in venture and private companies — comparable to Portfolia's direct-to-consumer LP community model, and previously identified as a co-investor/advisor relationship in Portfolia's broader network.

Broad incumbents

• Khosla Ventures: Large institutional venture firm with growing women's health and femtech exposure — represents the broader incumbent capital flowing into Portfolia's categories and a potential co-investor/competitor at the growth stages where Portfolia's portfolio companies raise.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Portfolia1
• Facebookfacebook.com/Portfolia1
• LinkedInlinkedin.com/company/portfolia

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries7 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments194 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Portfolia